Publications by authors named "Tobias Foierl"
Article Synopsis
- This study examined the stability of Sandoz rituximab biosimilar (SDZ-RTX) under various storage conditions, focusing on both in-use and out-of-fridge scenarios to ensure patient safety.
- The researchers subjected two SDZ-RTX batches to long-term refrigeration followed by exposure to higher temperatures and humidity to simulate real-world storage situations.
- Results indicated that SDZ-RTX maintained its physicochemical and biological quality, meeting strict acceptance criteria even after exposure to elevated temperatures, provided it was prepared in a sterile environment.
Health-related quality of life (HRQoL) data are important indicators of health status in patients with lymphoma. The objective of this analysis was to assess the impact of treatment with Sandoz rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) on HRQoL in treatment-naïve adult patients with diffuse large B-cell lymphoma (DLBCL) included in the prospective, real-world REFLECT study. REFLECT is the first prospective study to assess HRQoL in patients with DLBCL treated with a rituximab biosimilar.
View Article and Find Full Text PDF